Skip to main content
Journal cover image

Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint?

Publication ,  Journal Article
Halabi, S; Rini, BI; Escudier, B; Stadler, WM; Small, EJ
Published in: Cancer
June 1, 2015

Duke Scholars

Published In

Cancer

DOI

EISSN

1097-0142

Publication Date

June 1, 2015

Volume

121

Issue

11

Start / End Page

1906

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Male
  • Kidney Neoplasms
  • Interferon-alpha
  • Humans
  • Female
  • Carcinoma, Renal Cell
  • Antineoplastic Combined Chemotherapy Protocols
  • 4206 Public health
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Halabi, S., Rini, B. I., Escudier, B., Stadler, W. M., & Small, E. J. (2015). Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint? Cancer, 121(11), 1906. https://doi.org/10.1002/cncr.29252
Halabi, Susan, Brian I. Rini, Bernard Escudier, Walter M. Stadler, and Eric J. Small. “Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint?Cancer 121, no. 11 (June 1, 2015): 1906. https://doi.org/10.1002/cncr.29252.
Halabi S, Rini BI, Escudier B, Stadler WM, Small EJ. Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint? Cancer. 2015 Jun 1;121(11):1906.
Halabi, Susan, et al. “Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint?Cancer, vol. 121, no. 11, June 2015, p. 1906. Pubmed, doi:10.1002/cncr.29252.
Halabi S, Rini BI, Escudier B, Stadler WM, Small EJ. Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint? Cancer. 2015 Jun 1;121(11):1906.
Journal cover image

Published In

Cancer

DOI

EISSN

1097-0142

Publication Date

June 1, 2015

Volume

121

Issue

11

Start / End Page

1906

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Male
  • Kidney Neoplasms
  • Interferon-alpha
  • Humans
  • Female
  • Carcinoma, Renal Cell
  • Antineoplastic Combined Chemotherapy Protocols
  • 4206 Public health
  • 3211 Oncology and carcinogenesis